Trial site
Artemis Institute for Clinical Research
San Diego, California 92103, United StatesNot linked to an institution yet
- 17running trials
- 21closed trials
The trials here
What the 38 trials at this site are about, from their registry records.
- Phase
- Phase 324 trials
- Phase 27 trials
- Phase 1/23 trials
- Phase 2/32 trials
- Phase 42 trials
- Status
- Completed20 trials
- Active, not recruiting10 trials
- Recruiting6 trials
- Not yet recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Eli Lilly and Company16 trials
- Pfizer5 trials
- Janssen Research & Development, LLC4 trials
- BioNTech SE3 trials
- Amgen2 trials
- and 7 more
Running trials
Not yet recruiting
A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes
NCT07881432· Phase 3· Eli Lilly and Company· Source
Contact: Stacey Layle (principal investigator)
Recruiting
A Study of Esketamine Nasal Spray Versus Placebo Spray in Adult Participants With Treatment-resistant Depression
NCT07716098· Phase 3· Janssen Research & Development, LLC· Source
Recruiting
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
NCT07684235· Phase 3· Amgen· Source
Recruiting
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain
NCT07641517· Phase 2· Eli Lilly and Company· Source
Contact: Stacey Layle (principal investigator)
Recruiting
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
NCT07602582· Phase 3· Eli Lilly and Company· Source
Contact: Eric Chavez (principal investigator)
Recruiting
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
NCT07392190· Phase 3· Eli Lilly and Company· Source
Contact: Stacey Layle (principal investigator)
Recruiting
A Study of Brenipatide in Participants With Alcohol Use Disorder
NCT07219953· Phase 3· Eli Lilly and Company· Source
Recruiting
A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder
NCT07219966· Phase 3· Eli Lilly and Company· Source
Active, not recruiting
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
NCT07076407· Phase 3· Xenon Pharmaceuticals Inc.· Source
Active, not recruiting
A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back Pain
NCT07035093· Phase 3· Eli Lilly and Company· Source
Active, not recruiting
Evaluation of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight
NCT06858839· Phase 3· Amgen· Source
Active, not recruiting
A Study of Retatrutide (LY3437943) Compared to Tirzepatide (LY3298176) in Adults Who Have Obesity
NCT06662383· Phase 3· Eli Lilly and Company· Source
Active, not recruiting
A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)
NCT06653153· Phase 3· Eli Lilly and Company· Source
Active, not recruiting
A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity
NCT05556512· Phase 3· Eli Lilly and Company· Source
Active, not recruiting
A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3)
NCT05026866· Phase 3· Eli Lilly and Company· Source
Active, not recruiting
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
NCT04437511· Phase 3· Eli Lilly and Company· Source
Recruiting
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
NCT05986292· Phase 2· Eli Lilly and Company· Source
Contact: Stacey Layle (principal investigator)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Closed trials
Completed
A Study to Learn About How the Flu and COVID-19 Vaccines Act in Healthy People
NCT06821061· Phase 1/2· BioNTech SE· Source
Completed
A Study to Explore the Efficacy of JNJ-89495120 in the Treatment of Major Depressive Disorder
NCT06785012· Phase 2· Janssen Research & Development, LLC· Source
Completed
A Study to Learn About the Study Medicine Called PF-07976016 in Adults With Obesity
NCT06717425· Phase 2· Pfizer· Source
Completed
A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy People
NCT06683352· Phase 1/2· BioNTech SE· Source
Completed
A Master Protocol for Orforglipron in Participants With Obstructive Sleep Apnea and Obesity or Overweight
NCT06649045· Phase 3· Eli Lilly and Company· Source
Completed
INDV-6001 Multiple-Dose Pharmacokinetic Study
NCT06576843· Phase 2· Indivior Inc.· Source
Completed
A Study About Modified RNA Vaccines Against Influenza in Healthy Adults
NCT06436703· Phase 1/2· Pfizer· Source
Completed
Dose-Finding Study Evaluating Effect on Body Composition of Enobosarm in Patients Taking a GLP-1 for Chronic Weight Mgmt
NCT06282458· Phase 2· Veru Inc.· Source
Completed
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Combined Modified RNA Vaccine Candidate Against COVID-19 and Influenza.
NCT06178991· Phase 3· BioNTech SE· Source
Completed
A Study of 9-valent Extraintestinal Pathogenic Escherichia Coli Vaccine (ExPEC9V) and High-dose Quadrivalent Influenza Vaccine, With and Without Co-administration, in Adults Aged 65 Years or Older
NCT06134804· Phase 3· Janssen Research & Development, LLC· Source
Completed
A Study of Retatrutide (LY3437943) Once Weekly in Participants Who Have Obesity or Overweight and Osteoarthritis of the Knee
NCT05931367· Phase 3· Eli Lilly and Company· Source
Completed
A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight
NCT05929066· Phase 3· Eli Lilly and Company· Source
Completed
A Study to Learn About Two or More Vaccines That Are Put Together as One Shot Against Infectious Lung Illnesses, Including COVID-19 and Respiratory Syncytial Virus (RSV).
NCT05886777· Phase 2· Pfizer· Source
Completed
Efficacy, Safety, and Tolerability of COMP360 in Participants With TRD
NCT05624268· Phase 3· COMPASS Pathways· Source
Completed
Safety and Efficacy of Lorecivivint (SM04690) for the Treatment of Knee Osteoarthritis (STRIDES)
NCT05603754· Phase 3· Biosplice Therapeutics, Inc.· Source
Completed
A Study of mRNA-1010 Seasonal Influenza Vaccine in Adults 50 Years Old and Older
NCT05566639· Phase 3· ModernaTX, Inc.· Source
Completed
A Study to Evaluate a Modified RNA Vaccine Against Influenza in Adults 18 Years of Age or Older
NCT05540522· Phase 3· Pfizer· Source
Completed
Buprenorphine Extended-Release Subcutaneous Injection (RBP-6000) in High-risk Users
NCT04995029· Phase 4· Indivior Inc.· Source
Terminated
A Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention
NCT04804033· Phase 2/3· Pfizer· Source
Completed
A Study of Esketamine Nasal Spray, Administered as Monotherapy, in Adult Participants With Treatment-resistant Depression
NCT04599855· Phase 4· Janssen Research & Development, LLC· Source
Completed
Troriluzole (BHV-4157) in Adult Participants With Obsessive Compulsive Disorder
NCT03299166· Phase 2/3· Biohaven Pharmaceuticals, Inc.· Source
Report an error